TAC1 and Dystonia: Changes in other modulators of the direct and indirect pathways such as such as dynorphin, enkephalin, substance P and PDE10a may also play a role in development of dystonia, and future molecular studies measuring their levels in this NHP model during and after transient dystonia may prove informative regarding pathophysiologic mechanisms of transient dystonia.